Lexington, Massachusetts occupies a historic stretch of Middlesex County about twelve miles northwest of downtown Boston, sitting squarely in the suburban corridor that runs along Routes 2 and 128. The town is well-known for its Revolutionary War heritage, but for the thousands of families who have sought fertility care in the region, it is equally associated with one of New England's most established reproductive medicine programs. IVF New England has operated from its address at 1 Forbes Road in Lexington for many years, functioning as the clinical hub of a multi-site network that at its peak served patients across twelve locations in Massachusetts, New Hampshire, and Rhode Island—including offices in Cambridge, Worcester, Westborough, North Chelmsford, Milford, Gloucester, Braintree, North Dartmouth, Bedford, Portsmouth, and Providence. The practice was built around board-certified reproductive endocrinologists who trained at Harvard-affiliated hospitals, Brown University, and other leading academic medical centers, and it developed a reputation for personalized care within a system large enough to handle complex cases. Patient ratings across platforms including Glow and OVU place the practice at approximately 4.2 to 4.5 out of 5, with reviewers frequently citing the compassionate and organized approach of the clinical and nursing staff. The Lexington location served as the administrative and laboratory flagship for the broader network and has historically recorded well over 3,000 IVF cycles per year.
Physicians and Clinical Team
IVF New England built its clinical program around a group of reproductive endocrinologists who each completed subspecialty fellowship training after residency in Obstetrics and Gynecology. All physicians listed below hold dual board certification from the American Board of Obstetrics and Gynecology in both Obstetrics and Gynecology and in Reproductive Endocrinology and Infertility.
Samuel C. Pang, MD is one of the longest-serving and most recognized physicians affiliated with IVF New England. He earned his medical degree from the University of British Columbia in 1983 and went on to subspecialize in Reproductive Endocrinology, Endocrinology, and Obstetrics and Gynecology. Dr. Pang has been a consistent presence at IVF New England's Lexington, Milford, and Concord offices and has earned Castle Connolly Top Fertility Doctor recognition from 2013 through 2024 as well as Boston Magazine Top Fertility Doctor honors spanning 2013 through 2024. He is widely regarded among New England fertility specialists for his depth of clinical experience across the full spectrum of assisted reproductive technology, including complex IVF cases, recurrent pregnancy loss workups, and ovarian reserve assessment.
Isaac Z. Glatstein, MD completed his medical education at New York University Grossman School of Medicine, graduating in 1988, and then trained in Obstetrics and Gynecology at Mount Sinai School of Medicine in New York City. His subspecialty fellowship in Reproductive Endocrinology and Infertility was completed through Harvard Medical School at Brigham and Women's Hospital in Boston—one of the most competitive and research-intensive REI training programs in the country. Dr. Glatstein is board-certified in Reproductive Endocrinology and Infertility and has served as Associate Medical Director within the IVF New England network. He has been a recipient of the Patients' Choice Award every year since 2008 and received Compassionate Doctor Recognition in 2009 and 2010, reflecting the consistently positive feedback he receives from patients navigating infertility treatment.
Kerri L. Luzzo, MD earned her medical degree from the Medical College of Wisconsin and completed her residency in Obstetrics and Gynecology at Tufts New England Medical Center in Boston, where she served as administrative chief resident—an honor reflecting her leadership and clinical standing within the program. She then completed her subspecialty fellowship in Reproductive Endocrinology and Infertility at Washington University School of Medicine in St. Louis, one of the nation's premier academic REI programs. Dr. Luzzo is double board-certified in Obstetrics and Gynecology and Reproductive Endocrinology and Infertility. She holds a clinical appointment as Instructor in the Department of Family Medicine at Brown University's Alpert Medical School and serves as an ad hoc reviewer for the journal Fertility and Sterility. She is a member of the American Society for Reproductive Medicine (ASRM), the New England Fertility Society (NEFS), the American Congress of Obstetricians and Gynecologists (ACOG), and the Society for Gynecologic Investigation (SGI). She has been named a Castle Connolly Top Doctor from 2023 through 2025 and received the Providence Business News "40 Under 40" Award in 2021.
Kristen Wright, MD completed her residency training in Obstetrics and Gynecology at Brown University Medical School before earning her subspecialty fellowship in Reproductive Endocrinology and Infertility at the University of Vermont College of Medicine. She is double board-certified in Obstetrics and Gynecology and Reproductive Endocrinology and Infertility, and she holds an appointment as Clinical Assistant Professor at the Geisel School of Medicine at Dartmouth College. Dr. Wright has been recognized as a Castle Connolly Top Doctor from 2013 through 2025, a New Hampshire Magazine Top Doctor from 2017 through 2025, and has received the Exceptional Women in Medicine recognition from 2020 through 2025. She is also notable for establishing the first freestanding IVF clinic in New Hampshire and for successfully advocating for expanded state insurance coverage of infertility treatment in that state.
Samuel Pauli, MD and Carla DiGirolamo, MD, PhD round out the physician group with additional depth in infertility care and reproductive surgery. Dr. Pauli has earned Castle Connolly Top Fertility Doctor designation from 2017 through 2024 and Boston Magazine Top Fertility Doctor recognition spanning the same period. Dr. DiGirolamo holds both an MD and a PhD and has been recognized by Boston Magazine as a Top Doctor in infertility, underscoring the academic research background she brings to clinical practice.
Services and Treatments
IVF New England offers a full range of diagnostics and treatments for individuals and couples experiencing infertility, including:
- In Vitro Fertilization (IVF), including stimulated cycles and frozen embryo transfer (FET)
- Intrauterine Insemination (IUI)
- Intracytoplasmic Sperm Injection (ICSI)
- Preimplantation Genetic Diagnosis and Screening (PGD/PGS, now more precisely called PGT-M and PGT-A)
- Egg freezing and elective fertility preservation
- Ovulation induction and ovarian stimulation
- Donor egg IVF and donor embryo transfer
- Gestational carrier and surrogacy coordination
- Cryopreservation of embryos, eggs, and sperm
- Male factor infertility evaluation and treatment
- Reproductive surgery for structural conditions including uterine fibroids, polyps, and endometriosis
- Comprehensive fertility testing including ovarian reserve panels (AMH, antral follicle count), semen analysis, and hysterosalpingography (HSG)
- Mental health support and counseling integrated into the treatment pathway
- Care for single women, opposite-sex couples, same-sex couples, and veterans
The network's multi-location structure means patients in the greater Boston area, Merrimack Valley, central Massachusetts, and southern New Hampshire can access monitoring visits and consultations at the location most convenient to them, while retrievals and transfers are performed at the equipped surgical centers within the network.
Laboratory and Success Rates
The Lexington flagship serves as the primary embryology laboratory for the IVF New England network. A centralized, high-volume laboratory allows the embryology team to maintain strict quality control protocols and to accumulate significant experience with the most advanced culture and cryopreservation techniques. The practice's documented cycle volume—exceeding 3,000 IVF cycles in a single year at its operational peak, plus 49 egg banking cycles—places it among the higher-volume programs in New England, a factor that research consistently correlates with laboratory proficiency and consistent outcomes.
Prospective patients should review independently verified success rate data before choosing a fertility clinic. The most reliable source for this information is the federal reporting system administered by the Centers for Disease Control and Prevention, which collects annual ART outcome data from all SART-member clinics and publishes results broken down by patient age group, diagnosis, and cycle type. You can access this data at the CDC ART national reporting page. The Society for Assisted Reproductive Technology also publishes searchable clinic-level summaries at its SART online reporting portal. Because outcomes vary by age and diagnosis, patients are encouraged to compare data for their specific age bracket rather than relying on headline success rate figures.
Patient Experience
Patients who have reviewed IVF New England on platforms including Glow, Vitals, and OVU consistently highlight the warmth and responsiveness of the nursing staff and clinical coordinators. Reviewers describe a team that is organized, attentive, and communicative throughout what can be a physically and emotionally demanding treatment process. Multiple reviewers note that staff members take time to answer questions thoroughly and that patients generally feel they are in good hands from the initial consultation through retrieval and transfer cycles.
The practice has historically been inclusive in its patient intake, serving single women, opposite-sex couples, same-sex couples, and veterans—an important consideration for patients who have encountered less welcoming clinical environments elsewhere. The network's twelve-location footprint provided a practical advantage for patients in northern Massachusetts and southern New Hampshire who would otherwise face long drives to Boston for routine monitoring appointments. Early morning weekday availability for monitoring visits—a standard feature of high-volume fertility programs—accommodates patients managing treatment around full-time work schedules.
For patients requiring more specialized consultations or procedures, the Lexington location's proximity to the academic medical centers of the greater Boston area—including Harvard-affiliated hospitals where several IVF New England physicians completed their training—provides a natural referral pathway when complex reproductive surgery or subspecialty co-management is required.
Considering At-Home Insemination?
Not every fertility journey begins in a clinic. At-home intracervical insemination (ICI) is a lower-cost, private option that suits patients with no known fertility diagnosis — including single parents by choice, same-sex couples, and people who want to try a few cycles before committing to clinical treatment.
At-home insemination kits like those from MakeAMom come with step-by-step instructions designed for donor or partner sperm. Kits are a one-time purchase that can be reused until conception succeeds, require no clinic visit, and arrive in plain, discreet packaging. Many patients use them as a first step while working toward a fertility consultation — or alongside ovulation tracking while they wait for an appointment slot.
If you have a known fertility diagnosis, have been trying for 12 months without success (six months if you're over 35), or your physician has already recommended IUI or IVF, a board-certified reproductive endocrinologist is the right next step.
Insurance and Financing
Massachusetts has one of the most protective fertility insurance mandates in the United States. First enacted in 1987 as the second such law in the country, the Massachusetts mandate requires health insurance carriers that offer pregnancy-related benefits to also cover the diagnosis and treatment of infertility, including IVF and intrauterine insemination. The mandate applies to commercial insurers, non-profit hospital service corporations, medical service corporations, and HMOs operating in the state.
Under the Massachusetts law, infertility is defined as the inability to conceive after one year of unprotected intercourse for women age 35 or younger, or after six months for women over 35. Covered services include artificial insemination, IUI, IVF, and embryo transfer. This mandate makes Massachusetts one of the most favorable states in the country for patients seeking insurance coverage for fertility treatment—a meaningful financial advantage given that a single IVF cycle without coverage typically costs between $12,000 and $20,000 before medications.
Important limitations apply. Employers who self-insure their health plans under the federal Employee Retirement Income Security Act (ERISA) are not required to comply with state mandates, which in practice excludes a significant proportion of employees at large private-sector companies. Religious organizations may also be exempt. Patients should verify their specific plan terms with their employer and insurer before beginning treatment.
For patients without qualifying insurance coverage, financing options and payment plans are typically available. Patients in New Hampshire and Rhode Island, where IVF New England also maintained locations, should be aware that those states have their own evolving insurance mandates—New Hampshire and Rhode Island both provide some level of mandated coverage, though the specifics differ from Massachusetts law. For a broader overview of fertility care options in the state, see our guide to fertility clinics in Massachusetts.
Frequently Asked Questions
What is the difference between IVF New England and Boston IVF? IVF New England and Boston IVF are separate fertility practices that have both operated in the greater Boston area and across New England. IVF New England has historically maintained its administrative headquarters and primary embryology laboratory at 1 Forbes Road in Lexington, MA, with a network of satellite monitoring and consultation offices across the region. Boston IVF is a distinct practice that also has a Lexington location (at 450 Bedford Street) and operates its own multi-site network. Patients should confirm which practice and location they are scheduling with when seeking care in Lexington to avoid confusion between the two programs.
Does Massachusetts insurance cover IVF at IVF New England? Most commercial health insurance plans issued in Massachusetts are required by state law to cover medically necessary infertility treatment, including IVF. Coverage is subject to the definition of infertility under Massachusetts law and to the specific terms of an individual's plan. Self-insured employer plans operating under ERISA are not subject to the state mandate. IVF New England's financial counselors can review insurance benefits and estimate out-of-pocket costs before a patient begins treatment. For more on what to expect from a complete treatment cycle, see our in-depth guide to IVF.
What genetic testing options are available at IVF New England? IVF New England has offered Preimplantation Genetic Diagnosis (PGD) and Preimplantation Genetic Screening (PGS)—now commonly referred to as PGT-M (monogenic disease testing) and PGT-A (aneuploidy testing), respectively—as part of its IVF program. PGT-A is used to screen embryos for chromosomal abnormalities before transfer, which can improve implantation rates and reduce miscarriage risk, particularly for patients of advanced maternal age. PGT-M is used when one or both partners carry a known genetic condition that could be passed to a child. Patients who believe they may benefit from genetic testing should raise this with their physician at the initial consultation so that testing logistics can be incorporated into the treatment plan from the outset.
How many IVF cycles does IVF New England perform each year? At its operational peak, IVF New England reported over 3,000 IVF cycles per year across its network, in addition to dozens of egg banking cycles. High cycle volume is considered an important quality indicator in reproductive medicine because it supports laboratory staff proficiency, consistent embryo culture outcomes, and accumulated clinical experience with complex cases. Patients evaluating any fertility clinic should ask about annual cycle volume and review the practice's CDC-reported outcomes data for the most relevant comparison.